Effects of sitagliptin and vildagliptin on glucose fluctuations in patients with type 2 diabetes -prospective open-label controlled study-
Phase of Trial: Phase IV
Latest Information Update: 17 May 2016
At a glance
- Drugs Sitagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Sep 2014 Primary endpoint has been met, according to results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 19 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.
- 30 Apr 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.